Abstract
In the present study, some hydrazone derivatives were synthesized via the reaction of 3-cyclohexylpropionic acid hydrazide with various benzaldehydes. The chemical structures of the compounds were elucidated by spectroscopic techniques such as IR, 1H-NMR and FAB-MS and elemental analyses. The compounds were evaluated for their antiinflammatory and cytotoxic activities. Anti-inflammatory activity was determined in terms of inhibition of NF-κB, ROS generation and iNOS activity. Several derivatives inhibited NF-κB and iNOS, but no effect was observed on intracellular ROS generation. Furthermore no cytoxicity was observed. Biological activity compared with the chemical structural information suggests that different functional groups on the phenyl ring influence the physicochemical properties and thus modulate biological activity.
Keywords: Hydrazone, Anti-inflammatory activity, Cytotoxicity, Antioxidant activity, Inflammation, Nonsteroidal anti-inflammatory drugs (NSAIDs), COX, Hydrazone Derivative, 1H-NMR, inflammatory activity, Chemical shifts, Proton nuclear magnetic resonance, HL-60, non-fluorescent probe
Letters in Drug Design & Discovery
Title: Synthesis and Biological Evaluation of Some Hydrazone Derivatives as Anti-inflammatory Agents
Volume: 9 Issue: 3
Author(s): Zafer Asim Kaplancikli, Mehlika Dilek Altintop, Ahmet Ozdemir, Gulhan Turan-Zitouni, Shabana I. Khan and Nurhayat Tabanca
Affiliation:
Keywords: Hydrazone, Anti-inflammatory activity, Cytotoxicity, Antioxidant activity, Inflammation, Nonsteroidal anti-inflammatory drugs (NSAIDs), COX, Hydrazone Derivative, 1H-NMR, inflammatory activity, Chemical shifts, Proton nuclear magnetic resonance, HL-60, non-fluorescent probe
Abstract: In the present study, some hydrazone derivatives were synthesized via the reaction of 3-cyclohexylpropionic acid hydrazide with various benzaldehydes. The chemical structures of the compounds were elucidated by spectroscopic techniques such as IR, 1H-NMR and FAB-MS and elemental analyses. The compounds were evaluated for their antiinflammatory and cytotoxic activities. Anti-inflammatory activity was determined in terms of inhibition of NF-κB, ROS generation and iNOS activity. Several derivatives inhibited NF-κB and iNOS, but no effect was observed on intracellular ROS generation. Furthermore no cytoxicity was observed. Biological activity compared with the chemical structural information suggests that different functional groups on the phenyl ring influence the physicochemical properties and thus modulate biological activity.
Export Options
About this article
Cite this article as:
Asim Kaplancikli Zafer, Dilek Altintop Mehlika, Ozdemir Ahmet, Turan-Zitouni Gulhan, I. Khan Shabana and Tabanca Nurhayat, Synthesis and Biological Evaluation of Some Hydrazone Derivatives as Anti-inflammatory Agents, Letters in Drug Design & Discovery 2012; 9 (3) . https://dx.doi.org/10.2174/157018012799129828
DOI https://dx.doi.org/10.2174/157018012799129828 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brain Tumor Causes, Symptoms, Diagnosis and Radiotherapy Treatment
Current Medical Imaging Mechanisms of Beneficial Effects of High Molecular Weight Hyaluronan on Cultured Cartilage Tissue
Current Rheumatology Reviews EXTraordinary Bones: Functional and Genetic Analysis of the EXT Gene Family
Current Genomics Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Recent Patents on Biotechnology Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Current Gene Therapy Targeting the Tumor Stroma in Cancer Therapy
Current Pharmaceutical Biotechnology Multicolor-FISH Approaches for the Characterization of Human Chromosomes in Clinical Genetics and Tumor Cytogenetics
Current Genomics Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
Current Drug Targets Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Current Cancer Drug Targets CSPG4 in Cancer: Multiple Roles
Current Molecular Medicine Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers
Current Cancer Drug Targets Primary Tumors of the Sacrum: Imaging Findings
Current Medical Imaging Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry Current State of ERG as Biomarker in Prostatic Adenocarcinoma
Current Cancer Drug Targets Complications of Muscle Hematomas in Hemophilia
Cardiovascular & Hematological Disorders-Drug Targets The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment
Recent Patents on Anti-Cancer Drug Discovery Image Guided Biopsy of Musculoskeletal Lesions with Low Diagnostic Yield
Current Medical Imaging The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design Prognostic and Predictive Biomarkers in Cancer
Current Cancer Drug Targets